Internal Medicine, Critical Care Medicine · Cleveland, OH
NPI
1972523538
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
582 services
Medicare patients, 2024
231
Average age 71
Drug cost, 2024
$14.5M
2,162 prescriptions
Company payments, 2025
$81K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Schilz was code 99215 (office e&m - established), 93 times for 41 patients. In total Robert J Schilz billed 582 services in 20 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 93 | 41 | $106.09 | $9,867 |
| 94010 Pulmonary Function Testing | Facility | 81 | 69 | $5.92 | $479 |
| 94729 Pulmonary Function Testing | Facility | 68 | 67 | $6.40 | $435 |
| 94618 Pulmonary Function Testing | Facility | 59 | 51 | $15.60 | $920 |
| 99233 Hospital E&M - Subsequent | Facility | 51 | 17 | $90.13 | $4,597 |
| 94726 Pulmonary Function Testing | Facility | 44 | 44 | $8.62 | $379 |
| 94060 Pulmonary Function Testing | Facility | 37 | 36 | $7.31 | $271 |
| 99223 Hospital E&M - Initial | Facility | 32 | 31 | $130.51 | $4,176 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 15 | $59.91 | $1,857 |
| 99214 Office E&M - Established | Facility | 24 | 22 | $61.58 | $1,478 |
| 94621 Pulmonary Function Testing | Facility | 11 | 11 | $50.97 | $561 |
By year: 2022 $35K for 713 services; 2023 $29K for 467 services; 2024 $28K for 582 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Schilz prescribed most often to Medicare patients was Tadalafil, with 452 prescriptions and refills. In total Robert J Schilz wrote 2,162 Medicare prescriptions that cost $14.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tadalafil Generic | 452 | 480 | 53 | $308K |
| Opsumit Macitentan | 263 | 263 | 29 | $3.4M |
| Ambrisentan Generic | 222 | 222 | 25 | $673K |
| Orenitram Er Treprostinil Diolamine | 162 | 162 | Under 11 | $1.3M |
| Uptravi Selexipag | 156 | 156 | 17 | $3.4M |
| Tyvaso Dpi Treprostinil | 141 | 141 | Under 11 | $3.4M |
| Sildenafil Citrate Generic | 90 | 101 | 12 | $16K |
| Adempas Riociguat | 81 | 81 | Under 11 | $1.1M |
| Furosemide Generic | 69 | 111 | 20 | $205 |
| Potassium Chloride Generic | 67 | 101 | 13 | $1,418 |
| Digoxin Generic | 43 | 49 | Under 11 | $311 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 31 | 47 | Under 11 | $1,346 |
| Prednisone Generic | 26 | 40 | Under 11 | $145 |
| Letairis Ambrisentan | 24 | 24 | Under 11 | $306K |
| Torsemide Generic | 22 | 34 | Under 11 | $707 |
Brand drugs: - claims; generic drugs: 1,211 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Schilz $81K ($81K in general payments such as food, travel and fees) from 13 companies. The largest payer was United Therapeutics Corporation with $29K.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 43 | $29K |
| Actelion Pharmaceuticals US, Inc. JNJ | 20 | $21K |
| Merck Sharp & Dohme LLC MRK | 13 | $17K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $14K |
| Inari Medical, Inc. | 1 | $167 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $49.41 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $48.28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.24 |
| Liquidia Technologies, Inc. | 1 | $23.59 |
| BridgeBio Pharma, Inc. BBIO | 1 | $22.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.